The Liver Meeting 2023-2023 TLM Debrief Session (Hepatitis Debrief)

Video Transcription

Video Summary

Dr. Jennifer Price from UCSF provided a comprehensive overview of viral hepatitis, focusing on key themes and highlights from the recent liver meeting. She discussed the ongoing challenges in viral hepatitis elimination, including updated prevalence estimates for hepatitis C in the United States. Dr. Price also highlighted innovative models of care delivery, such as telemedicine-based treatment for people with opioid use disorder. Additionally, she discussed special populations, including hepatitis C in pregnancy and liver transplant recipients. In hepatitis B, Dr. Price covered optimizing therapies, comparing tenofovir and entecavir, and potential novel therapeutics for achieving functional cure. The presentation also touched on screening barriers in Asian American communities and promising research on treatments for hepatitis delta. Dr. Price emphasized the importance of ongoing research and collaboration in addressing the complexities of viral hepatitis.

Asset Caption

Jennifer Price, MD, PhD: Hepatitis Debrief

Keywords

viral hepatitis

liver meeting

hepatitis C

telemedicine

hepatitis B

treatment options

research collaboration